Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
AUTOR(ES)
He, Wanxia
FONTE
American Society for Microbiology
RESUMO
Addition of human papillomavirus (HPV) E7 CDK2/cyclin A or CDK2/cyclin E, purified from either insect cells or bacteria, dramatically upregulates histone H1 kinase activity. Activation is substrate specific, with a smaller effect noted for retinoblastoma protein (Rb). The CDK2 stimulatory activity is equivalent in high-risk (HPV type 16 [HPV16] and HPV31) and low-risk (HPV6b) E7. Mutational analyses of HPV16 E7 indicate that the major activity resides in amino acids 9 to 38, spanning CR1 and CR2, and does not require casein kinase II or Rb-binding domain functions. Synthetic peptides spanning HPV16 amino acid residues 9 to 38 also activate CDK2. Peptides containing this sequence that carry biotin on the carboxy terminus, as well as a photoactivated cross-linking group (benzophenone), also activate the complex and covalently associate with the CDK2/cyclin A complex in a specific manner requiring UV. Cross-linking studies that use protein monomers detect association of the E7 peptides with cyclin A but not CDK2. Together, our results indicate a novel mechanism whereby E7 promotes HPV replication by directly altering CDK2 activity and substrate specificity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=228519Documentos Relacionados
- Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
- Activation of the Bur1-Bur2 Cyclin-Dependent Kinase Complex by Cak1
- Activation of human cyclin-dependent kinases in vitro.
- Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins
- Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.